
"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This trial is looking at a new drug called CXD101 alongside nivolumab for bowel cancer that has spread elsewhere in the body.
It is for people who have a certain type of bowel cancer called microsatellite stable.
Bowel cancers have different types of changes in the DNA. A small number of bowel cancers have DNA changes called microsatellite instability. Most bowel cancers do not have these changes and are called microsatellite stable. This is the most common type of advanced bowel cancer.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Rachel Kerr
Celleron Therapeutics Ltd
Freephone 0808 800 4040
"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”